Cantor Fitzgerald, L. P.
- SEC CIK
- 0001024896
- Latest filing
- Aug 19, 2026
MCRB holding history
Seres Therapeutics, Inc. in every 13F filed by Cantor Fitzgerald, L. P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MCRB overviewAll 13F holders of MCRBFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −1,874−100.0% | Sold outConverted for a 1-for-20 split | Holders |
| Q1 2025 | 37,475 | $26.2K | <0.1% | −58,265−60.9% | Reduced | Holders |
| Q4 2024 | 95,740 | $79.6K | <0.1% | −184,825−65.9% | Reduced | Holders |
| Q3 2024 | 280,565 | $265.4K | <0.1% | +280,565 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −97,407−100.0% | Sold out | Holders |
| Q2 2023 | 97,407 | $466.6K | <0.1% | +97,407 | New | Holders |